Council of Scientific and Industrial Research

Other

Subhash Chander Sharma

Rakesh Kamal Johri

Ghulam Nabi Qazi

Ashok Kumar Tikoo

Kasturi Lal Bedi

Naresh Kumar Satti

Krishan Avtar Suri

Om Parkash Suri

Inshad Ali Khan

Vijeshwar Verma

Bishan Datt Gupta

Manoj Kumar Tikoo

Jhillu Singh Yadav

Santu Bandyopadhyay

Subhash Chandra Taneja

Anamika Khajuria

Surrinder Koul

Ashwani Kumar

Siddhartha Roy

Bal Krishan Kapahi

Jawahir Lal Koul

Pankaj Gupta

Bholanath Paul

Radha Krishna Palakodety

Ravi Kant Khajuria

Arun Bandyopadhyay

Mabalirajan Ulaganathan

Vasanta Madhava Sharma Gangavaram

Zahid Mehmood Mirza

Surjit Singh

Monika Pandita

Anita Khosa

Aditya Konar

Balaram Ghosh

Balram Ghosh

Randhir S Kapil

Sakshi Balwani

Gurdarshan Singh

Sheikh Tasaduq Abdullah

Manoj K Tickoo

Gurbax Singh

Ashok K Tickoo

Rajinder Singh

Mumu Chakraborty

Jawahar L Kaul

Ram K Zutshi

Gurcharan S Pahwa

Ramesh K Johri

Surjeet Singh

Uma Kaul

Naveen Kapoor

Santosh K Dhar

Usha Zutshi

Ashok Kumar Saxena

Sheikh Tasaduq Absullah

Debaprasad Jana

Tanima Banerjee

Dipak Kar

Tulika Mukherjee

Sibabrata Mukhopadhyay

A novel heterocyclic compound belonging to 'triazine-aryl-bis-indoles', useful for the treatment of asthma. The pathway by which this compound inhibits asthma is also demonstrated. The present invention also provides a process for the preparation of above compounds and their derivatives are presented.

Triazine-aryl-bis-indoles and process for preparation thereof

The present invention relates to an aromatic substituted pentadienoic acid amides and there use in combination of specific amounts of aromatic amides i.e. 4-alkyl-5-(substituted phenyl)-2 (E),4(E)-pentadienoic acid amides, its geometrical isomers or their dihydro or tetrahydro derivatives and an anti-infective drug useful in potentiating the bioefficacy of antiinfective drug. The combination of the present invention is useful in the treatment of certain infections and disease at lower concentration of anti-infectives necessary to inhibit the growth of microbial strains and may also find applications in reducing the resistance in microorganisms.

Aromatic amides as potentiators of bioefficacy of anti-infective drugs

The present invention relates to an aromatic substituted pentadienoic acid amides and there use in combination of specific amounts of aromatic amides i.e. 4-alkyl-5-(substituted phenyl)-2(E),4(E)-pentadienoic acid amides, its geometrical isomers or their dihydro or tetrahydro derivatives and an anti-infective drug useful in potentiating the bioefficacy of antiinfective drug. The combination of the present invention is useful in the treatment of certain infections and disease at lower concentration of anti-infectives necessary to inhibit the growth of microbial strains and may also find applications in reducing the resistance in microorganisms.

The present invention relates to a method for the treatment of bronchial asthma and chronic obstructive pulmonary disease (COPD) comprising administering to the patient suffering from asthma and COPD an effective dose of carbazole derivatives or salt thereof, optionally along with pharmaceutically acceptable excipients. Structural formula of the compounds of general formula 1 useful as phosphodiesterase-4 (PDE-4) enzyme inhibitors, inhibitor for signalling molecule for the treatment of asthma and asthma related diseases is given below:  Herbal route for the isolation of compound of general formula 1 from the bark of plantand chemical route for the preparation of such compounds from basic compounds such as vanillin is also reported.

Method for treatment of bronchial asthma

The present invention relates to a bioenhancing/bioavailability-facilitating composition comprising:

[object Object]

The present invention relates to the use of bioenhancers to decrease the resistance of microbial strains to anti-infective such an antibiotics and antifungals by potentiating the activities of anti-infective. This may be useful to reduce resistance in bacteria and yeast to aid in the treatment of certain infections and disease and to lower the concentration of antiinfectives necessary to inhibit the growth of microbial strains.

Use of herbal agents for potentiation of bioefficacy of anti infectives

A new pharmaceutical composition for the treatment of tuberculosis and leprosy, said composition comprising piperine in combination with known antituberculosis or antileprosy drugs or the mixtures thereof.

Process for preparation of pharmaceutical composition with enhanced

Growing community of inventors

Jammu, India

Subhash Chander Sharma